Table 3 Assessment of the percentage of cell types expressing TNFα in patients with NSCLC in above median survival patients in the islets (AMSI) and stroma (AMSS) and below median survival patients in the islets (BMSI) and stroma (BMSS).
| AMSI | AMSS | BMSI | BMSS | |
|---|---|---|---|---|
| % of cells which were Macrophages |
61.8* (9.4-100) |
76.9† (16.6-100) |
22.2 (5-71.5) |
39.7 (0-61.9) |
| % of cells which were mast cells |
45.2# (20.3-58.4) |
54.9¶ (0-79.1) |
5.6 (0-100) |
10.5 (0-55) |
| Estimated % of other cell types | 0 | 0 | 72 | 50 |